Systemic mRNA aggregates elicit immunologic reprogramming that unlocks anti-cancer immunity

Successful cancer immunotherapy requires novel approaches that overcome intratumoral immunosuppression and peripheral tolerance. In a recent manuscript describing intravenously administered mRNA-loaded lipid particle aggregates (RNA-LPAs), we demonstrate the ability to reprogram both the tumor micro...

Full description

Saved in:
Bibliographic Details
Main Authors: Hector R. Mendez-Gomez, John A. Ligon, Ashley P. Ghiaseddin, Elias J. Sayour
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/21645515.2025.2543599
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849233709068189696
author Hector R. Mendez-Gomez
John A. Ligon
Ashley P. Ghiaseddin
Elias J. Sayour
author_facet Hector R. Mendez-Gomez
John A. Ligon
Ashley P. Ghiaseddin
Elias J. Sayour
author_sort Hector R. Mendez-Gomez
collection DOAJ
description Successful cancer immunotherapy requires novel approaches that overcome intratumoral immunosuppression and peripheral tolerance. In a recent manuscript describing intravenously administered mRNA-loaded lipid particle aggregates (RNA-LPAs), we demonstrate the ability to reprogram both the tumor microenvironment and periphery enabling cancer-specific immunity simultaneously generated to compete against immunologically ‘cold’ malignancies like glioblastoma.
format Article
id doaj-art-f0ba26ca79d74d1b8de9042fcd4b9b15
institution Kabale University
issn 2164-5515
2164-554X
language English
publishDate 2025-12-01
publisher Taylor & Francis Group
record_format Article
series Human Vaccines & Immunotherapeutics
spelling doaj-art-f0ba26ca79d74d1b8de9042fcd4b9b152025-08-20T04:03:26ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2025-12-0121110.1080/21645515.2025.2543599Systemic mRNA aggregates elicit immunologic reprogramming that unlocks anti-cancer immunityHector R. Mendez-Gomez0John A. Ligon1Ashley P. Ghiaseddin2Elias J. Sayour3Lillian S. Wells Department of Neurosurgery, University of Florida, Gainesville, FL, USADepartment of Pediatrics, Division of Pediatric Hematology-Oncology, University of Florida, Gainesville, FL, USALillian S. Wells Department of Neurosurgery, University of Florida, Gainesville, FL, USALillian S. Wells Department of Neurosurgery, University of Florida, Gainesville, FL, USASuccessful cancer immunotherapy requires novel approaches that overcome intratumoral immunosuppression and peripheral tolerance. In a recent manuscript describing intravenously administered mRNA-loaded lipid particle aggregates (RNA-LPAs), we demonstrate the ability to reprogram both the tumor microenvironment and periphery enabling cancer-specific immunity simultaneously generated to compete against immunologically ‘cold’ malignancies like glioblastoma.https://www.tandfonline.com/doi/10.1080/21645515.2025.2543599mRNA vaccinescancerimmunotherapy
spellingShingle Hector R. Mendez-Gomez
John A. Ligon
Ashley P. Ghiaseddin
Elias J. Sayour
Systemic mRNA aggregates elicit immunologic reprogramming that unlocks anti-cancer immunity
Human Vaccines & Immunotherapeutics
mRNA vaccines
cancer
immunotherapy
title Systemic mRNA aggregates elicit immunologic reprogramming that unlocks anti-cancer immunity
title_full Systemic mRNA aggregates elicit immunologic reprogramming that unlocks anti-cancer immunity
title_fullStr Systemic mRNA aggregates elicit immunologic reprogramming that unlocks anti-cancer immunity
title_full_unstemmed Systemic mRNA aggregates elicit immunologic reprogramming that unlocks anti-cancer immunity
title_short Systemic mRNA aggregates elicit immunologic reprogramming that unlocks anti-cancer immunity
title_sort systemic mrna aggregates elicit immunologic reprogramming that unlocks anti cancer immunity
topic mRNA vaccines
cancer
immunotherapy
url https://www.tandfonline.com/doi/10.1080/21645515.2025.2543599
work_keys_str_mv AT hectorrmendezgomez systemicmrnaaggregateselicitimmunologicreprogrammingthatunlocksanticancerimmunity
AT johnaligon systemicmrnaaggregateselicitimmunologicreprogrammingthatunlocksanticancerimmunity
AT ashleypghiaseddin systemicmrnaaggregateselicitimmunologicreprogrammingthatunlocksanticancerimmunity
AT eliasjsayour systemicmrnaaggregateselicitimmunologicreprogrammingthatunlocksanticancerimmunity